• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical characteristics, antimicrobial resistance and capsular types of community-acquired, healthcare-associated, and nosocomial bacteremia.社区获得性、医疗保健相关性和医院获得性菌血症的临床特征、抗菌药物耐药性和荚膜型。
Antimicrob Resist Infect Control. 2019 Jan 3;8:1. doi: 10.1186/s13756-018-0426-x. eCollection 2019.
2
Clinical and microbiological characteristics of nosocomial, healthcare-associated, and community-acquired Klebsiella pneumoniae infections in Guangzhou, China.中国广州医院获得性、医疗保健相关性和社区获得性肺炎克雷伯菌感染的临床和微生物学特征。
Antimicrob Resist Infect Control. 2021 Feb 25;10(1):41. doi: 10.1186/s13756-021-00910-1.
3
Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection.社区获得性与医院获得性肺炎克雷伯菌感染菌血症的特征:死亡率的危险因素及荚膜血清型作为社区获得性感染先兆的影响
Arch Intern Med. 2002 May 13;162(9):1021-7. doi: 10.1001/archinte.162.9.1021.
4
Clinical characteristics of patients with pneumonia caused by in Taiwan and prevalence of antimicrobial-resistant and hypervirulent strains: a retrospective study.台湾地区肺炎克雷伯菌感染患者的临床特征和抗菌药物耐药及强毒力株的流行情况:一项回顾性研究。
Antimicrob Resist Infect Control. 2020 Jan 3;9(1):4. doi: 10.1186/s13756-019-0660-x. eCollection 2020.
5
Changing trends in clinical characteristics and antibiotic susceptibility of bacteremia.菌血症临床特征及抗生素敏感性的变化趋势
Korean J Intern Med. 2018 May;33(3):595-603. doi: 10.3904/kjim.2015.257. Epub 2017 Nov 10.
6
High mortality among patients infected with hypervirulent antimicrobial-resistant capsular type K1 Klebsiella pneumoniae strains in Taiwan.高死亡率患者感染高毒力抗微生物耐药荚膜型 K1 肺炎克雷伯菌菌株在台湾。
Int J Antimicrob Agents. 2018 Aug;52(2):251-257. doi: 10.1016/j.ijantimicag.2018.06.008. Epub 2018 Jun 12.
7
Whole genome analysis of hypervirulent Klebsiella pneumoniae isolates from community and hospital acquired bloodstream infection.社区获得性和医院获得性血流感染高毒力肺炎克雷伯菌分离株的全基因组分析。
BMC Microbiol. 2018 Jan 8;18(1):6. doi: 10.1186/s12866-017-1148-6.
8
Characteristics of healthcare-associated and community-acquired Klebsiella pneumoniae bacteremia in Taiwan.台湾地区医源性和社区获得性肺炎克雷伯菌菌血症的特征。
J Infect. 2012 Feb;64(2):162-8. doi: 10.1016/j.jinf.2011.11.005. Epub 2011 Nov 11.
9
Hypervirulent is emerging as an increasingly prevalent pathotype responsible for nosocomial and healthcare-associated infections in Beijing, China.高毒力已成为一种日益流行的血清型,可导致中国北京的医院感染和医源性感染。
Virulence. 2020 Dec;11(1):1215-1224. doi: 10.1080/21505594.2020.1809322.
10
Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae.产超广谱β-内酰胺酶肺炎克雷伯菌所致社区获得性血流感染的流行病学和临床特征。
Microb Drug Resist. 2011 Jun;17(2):267-73. doi: 10.1089/mdr.2010.0134. Epub 2011 Mar 9.

引用本文的文献

1
Phenotypic and genotypic ınvestigation of virulence factors in Klebsiella pneumoniae strains ısolated from ventilator-associated pneumonia (VAP) cases.对从呼吸机相关性肺炎(VAP)病例中分离出的肺炎克雷伯菌菌株毒力因子的表型和基因型研究。
Folia Microbiol (Praha). 2025 Jul 28. doi: 10.1007/s12223-025-01302-3.
2
Drug resistant Klebsiella pneumoniae from patients and hospital effluent: a correlation?来自患者和医院污水的耐药性肺炎克雷伯菌:存在相关性吗?
BMC Microbiol. 2025 May 11;25(1):284. doi: 10.1186/s12866-025-03987-5.
3
Chlorpromazine inhibits the plasmid-mediated oqxAB multidrug efflux pump in Escherichia coli isolates of Egyptian patients with utis.氯丙嗪可抑制埃及尿路感染患者大肠杆菌分离株中质粒介导的oqxAB多药外排泵。
BMC Microbiol. 2025 Mar 26;25(1):171. doi: 10.1186/s12866-025-03850-7.
4
High proportions of multidrug-resistant Klebsiella pneumoniae isolates in community-acquired infections, Brazil.巴西社区获得性感染中多重耐药肺炎克雷伯菌分离株的高比例。
Sci Rep. 2025 Mar 20;15(1):9698. doi: 10.1038/s41598-025-92549-w.
5
Prognostic Factors and Nomogram for Infections in Intensive Care Unit.重症监护病房感染的预后因素与列线图
Infect Drug Resist. 2025 Mar 1;18:1237-1251. doi: 10.2147/IDR.S500523. eCollection 2025.
6
Systematic review and meta-analysis of colistin heteroresistance in Klebsiella pneumoniae isolates.肺炎克雷伯菌分离株中黏菌素异质性耐药的系统评价和荟萃分析
BMC Infect Dis. 2025 Feb 12;25(1):207. doi: 10.1186/s12879-025-10600-7.
7
An integrative review on the risk factors, prevention, and control strategies for carbapenem-resistant colonization in critically ill patients.危重症患者耐碳青霉烯类定植的危险因素、预防及控制策略的综合综述
Front Microbiol. 2025 Jan 10;15:1519906. doi: 10.3389/fmicb.2024.1519906. eCollection 2024.
8
Antimicrobials profiling, biofilm formation, and clonal lineage of methicillin-resistant isolated from cockroaches.从蟑螂中分离出的耐甲氧西林菌株的抗菌谱、生物膜形成及克隆谱系
Heliyon. 2025 Jan 3;11(1):e41698. doi: 10.1016/j.heliyon.2025.e41698. eCollection 2025 Jan 15.
9
Human and Veterinary Medicine Collaboration: Synergistic Approach to Address Antimicrobial Resistance Through the Lens of Planetary Health.人类与兽医学合作:通过全球健康视角应对抗菌药物耐药性的协同方法。
Antibiotics (Basel). 2025 Jan 6;14(1):38. doi: 10.3390/antibiotics14010038.
10
High prevalence of fecal carriage of extended-spectrum beta-lactamase producing among patients with urinary tract infections in rural Tanzania.坦桑尼亚农村地区尿路感染患者中产超广谱β-内酰胺酶粪便携带率高。
Front Microbiol. 2025 Jan 6;15:1517182. doi: 10.3389/fmicb.2024.1517182. eCollection 2024.

本文引用的文献

1
Getting hypervirulent Klebsiella pneumoniae on the radar screen.引起关注的高毒力肺炎克雷伯菌。
Curr Opin Infect Dis. 2018 Aug;31(4):341-346. doi: 10.1097/QCO.0000000000000464.
2
Molecular Epidemiology of Klebsiella pneumoniae Strains Causing Bloodstream Infections in Adults.引起成人血流感染的肺炎克雷伯菌菌株的分子流行病学
Microb Drug Resist. 2018 Sep;24(7):949-957. doi: 10.1089/mdr.2017.0107. Epub 2017 Dec 11.
3
Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance.肺炎克雷伯菌:抗生素耐药性的主要全球来源和传播媒介。
FEMS Microbiol Rev. 2017 May 1;41(3):252-275. doi: 10.1093/femsre/fux013.
4
Risk Factors, Outcomes, and Mechanisms of Tigecycline-Nonsusceptible Klebsiella pneumoniae Bacteremia.替加环素不敏感肺炎克雷伯菌血流感染的危险因素、结局及机制
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7357-7363. doi: 10.1128/AAC.01503-16. Print 2016 Dec.
5
Community-onset Klebsiella pneumoniae pneumonia in Taiwan: clinical features of the disease and associated microbiological characteristics of isolates from pneumonia and nasopharynx.台湾社区获得性肺炎克雷伯菌肺炎:疾病的临床特征及肺炎和鼻咽部分离株的相关微生物学特征。
Front Microbiol. 2015 Feb 18;9:122. doi: 10.3389/fmicb.2015.00122. eCollection 2015.
6
Klebsiella pneumoniae liver abscess: a new invasive syndrome.肺炎克雷伯菌肝脓肿:一种新的侵袭性综合征。
Lancet Infect Dis. 2012 Nov;12(11):881-7. doi: 10.1016/S1473-3099(12)70205-0.
7
Differences in characteristics between healthcare-associated and community-acquired infection in community-onset Klebsiella pneumoniae bloodstream infection in Korea.韩国社区获得性肺炎克雷伯菌血流感染中,医源性感染与社区获得性感染在特征上的差异。
BMC Infect Dis. 2012 Oct 3;12:239. doi: 10.1186/1471-2334-12-239.
8
Characteristics of healthcare-associated and community-acquired Klebsiella pneumoniae bacteremia in Taiwan.台湾地区医源性和社区获得性肺炎克雷伯菌菌血症的特征。
J Infect. 2012 Feb;64(2):162-8. doi: 10.1016/j.jinf.2011.11.005. Epub 2011 Nov 11.
9
The role of Klebsiella pneumoniae rmpA in capsular polysaccharide synthesis and virulence revisited.重新探讨肺炎克雷伯菌 rmpA 基因在荚膜多糖合成和毒力中的作用。
Microbiology (Reading). 2011 Dec;157(Pt 12):3446-3457. doi: 10.1099/mic.0.050336-0. Epub 2011 Sep 29.
10
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.耐多药、广泛耐药和全耐药细菌:获得性耐药的国际专家临时标准定义建议
Clin Microbiol Infect. 2012 Mar;18(3):268-81. doi: 10.1111/j.1469-0691.2011.03570.x. Epub 2011 Jul 27.

社区获得性、医疗保健相关性和医院获得性菌血症的临床特征、抗菌药物耐药性和荚膜型。

Clinical characteristics, antimicrobial resistance and capsular types of community-acquired, healthcare-associated, and nosocomial bacteremia.

机构信息

1Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Number 201, Section 2, Shih-Pai Road, Beitou District, Taipei, 11217 Taiwan.

2Department of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.

出版信息

Antimicrob Resist Infect Control. 2019 Jan 3;8:1. doi: 10.1186/s13756-018-0426-x. eCollection 2019.

DOI:10.1186/s13756-018-0426-x
PMID:30622702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6318907/
Abstract

BACKGROUND

bacteremia is a major cause of morbidity and mortality worldwide. We aimed to compare the clinical characteristics, distribution of capsular types, and antimicrobial resistance of bacteremia among community-acquired (CA), healthcare-associated (HCA), and nosocomial infections.

METHODS

This retrospective study of patients with bacteremia was conducted at Taipei Veterans General Hospital from January to December 2015. Clinical characteristics of bacteremia were collected. The isolates were subjected to antimicrobial susceptibility testing and capsular genotyping.

RESULTS

In total, 337 patients with bacteremia were identified: 70 (20.8%), 102 (30.3%), and 165 (48.9%) presented with CA, HCA, and nosocomial infection, respectively. The 28-day mortality of HCA bacteremia was lower than that of nosocomial bacteremia (17.6% versus 30.9%,  = 0.016); however, that of the HCA and CA bacteremia was similar (17.6% versus 14.3%,  = 0.557). CA isolates had the highest prevalence of virulent capsular types (51.4%), followed by HCA (36.3%) and nosocomial isolates (19.4%). The proportion of multidrug-resistant (MDR) isolates was highest in nosocomial infections (41.8%), followed by HCA (23.5%) and CA infections (5.7%).

CONCLUSION

CA, HCA and nosocomial are distinct entities, as evidenced by the differences in clinical characteristics, antimicrobial resistance, and capsular types found in this study.

摘要

背景

菌血症是全球发病率和死亡率的主要原因。我们旨在比较社区获得性(CA)、医疗保健相关性(HCA)和医院获得性感染的菌血症的临床特征、荚膜型分布和抗菌药物耐药性。

方法

这项回顾性研究是在 2015 年 1 月至 12 月期间在台北荣民总医院对菌血症患者进行的。收集菌血症患者的临床特征。对分离株进行抗菌药物敏感性试验和荚膜基因分型。

结果

共确定 337 例菌血症患者:70 例(20.8%)、102 例(30.3%)和 165 例(48.9%)分别为 CA、HCA 和医院获得性感染。HCA 菌血症的 28 天死亡率低于医院获得性菌血症(17.6%比 30.9%,=0.016);然而,HCA 和 CA 菌血症的死亡率相似(17.6%比 14.3%,=0.557)。CA 分离株的毒力荚膜型患病率最高(51.4%),其次是 HCA(36.3%)和医院分离株(19.4%)。耐多药(MDR)分离株的比例在医院感染中最高(41.8%),其次是 HCA(23.5%)和 CA 感染(5.7%)。

结论

CA、HCA 和医院获得性感染是不同的实体,本研究发现它们在临床特征、抗菌药物耐药性和荚膜型方面存在差异。